QS-21 and its Role in Adjuvant Selection for Enhancing Vaccine Efficacy

In the field of immunology and vaccine development, adjuvants are vital components that enhance the immune response elicited by vaccines. One such adjuvant, QS-21, a natural product extracted from the bark of the soap bark tree (Quillaja saponaria), is an attractive candidate for use in vaccines.

Protein Concentration Determination

Protein concentration determination is critical in the development and production of biopharmaceuticals for several reasons:

Blue Mountain System

Equipment that complies with good manufacturing practice (GMP) is essential for producing pharmaceutical products that are pure, safe and effective. The design, function, qualification and control of such equipment must meet high standards in the manufacture of these products.

Amaran Biotech to participate BIO Asia-Taiwan 2024

BIO Asia–Taiwan 2024, an international gathering jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO); will be held from July 24th to 28th at the Taipei Nangang Exhibition Center. Amaran Biotech’s booth(#M413) will be located at CDMO (Contract Development and Manufacturing Organization) zone, please visit us and meet with our representatives.

High Risk from Human Intervention during Aseptic Filling

It is well known that human intervention increases the risk of finished product sterility failure during the aseptic filling process. For traditional aseptic filling lines using RABS, human intervention is often required, such as adjusting conveyor belts, turntables, vibrating bowls, star wheels through gloves.

Aseptic Filling Quality Standards and Cytiva SA25

When it comes to the production of sterile products, EU GMP Annex 1 is the highest standard that pharmaceutical manufacturers must adhere to. To provide a Class A environment and ensure sterility, barrier technology (either isolators or RABS) is the best solution to address critical factors such as quality of air, material and ingredient transfer, decontamination, etc. mentioned in Annex 1.

Sustainability of Adjuvant Development

As a socially responsible biotech company, Amaran continuously adopts eco-friendly practices that benefit not only the environment but also a healthier company culture and potentially cost saving.

【Distinguished Alumni Publication of FJCU】Distinguished Alumni of Fu-Jen Catholic University 2021

Amaran Biotech to participate BIO Asia-Taiwan 2023

BIO Asia–Taiwan 2023, an international gathering jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO); will be held from July 27th to 30th at the Taipei Nangang Exhibition Center, Hall 1 (TaiNEX 1).

Amaran Biotech to participate BIO International Convention 2023

The world's largest biotechnology industry event "BIO International Convention 2023" will be held at the Boston Convention & Exhibition Center on June 5-8. Amaran Biotech, is invited by the Biotechnology and Pharmaceutical Industries Promotion Office, Ministry of Economic Affairs (BPIPO, MOEA) and the Taiwan External Trade Development Council (TAITRA), will jointly exhibit at the "Taiwan Pavilion".

【CLEANROOM TECHNOLOGY】Amaran Biotechnology installs first gloveless isolator of its kind in Taiwan

【The Korea Herald】Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31